rs756614404
Variant summary
Our verdict is Pathogenic. Variant got 14 ACMG points: 14P and 0B. PVS1_StrongPM2PP5_Very_Strong
The NM_006736.6(DNAJB2):c.352+1G>A variant causes a splice donor, intron change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000013 in 1,613,970 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Pathogenic (★★).
Frequency
Consequence
NM_006736.6 splice_donor, intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 14 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DNAJB2 | NM_006736.6 | c.352+1G>A | splice_donor_variant, intron_variant | ENST00000336576.10 | NP_006727.2 | |||
DNAJB2 | NM_001039550.2 | c.352+1G>A | splice_donor_variant, intron_variant | NP_001034639.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DNAJB2 | ENST00000336576.10 | c.352+1G>A | splice_donor_variant, intron_variant | 1 | NM_006736.6 | ENSP00000338019.5 |
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152162Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000358 AC: 9AN: 251172Hom.: 0 AF XY: 0.0000442 AC XY: 6AN XY: 135782
GnomAD4 exome AF: 0.0000123 AC: 18AN: 1461808Hom.: 0 Cov.: 32 AF XY: 0.0000124 AC XY: 9AN XY: 727198
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152162Hom.: 0 Cov.: 33 AF XY: 0.0000135 AC XY: 1AN XY: 74328
ClinVar
Submissions by phenotype
Neuronopathy, distal hereditary motor, autosomal recessive 5 Pathogenic:3
Pathogenic, no assertion criteria provided | literature only | OMIM | Apr 01, 2012 | - - |
Pathogenic, no assertion criteria provided | clinical testing | Mendelics | Aug 08, 2014 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 31, 2024 | This sequence change affects a donor splice site in intron 5 of the DNAJB2 gene. RNA analysis indicates that disruption of this splice site induces altered splicing and may result in an absent or disrupted protein product. This variant is present in population databases (rs756614404, gnomAD 0.03%). Disruption of this splice site has been observed in individuals with Charcot-Marie-Tooth disease (PMID: 22522442, 27083531). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 217886). Algorithms developed to predict the effect of variants on protein structure and function are not available or were not evaluated for this variant. Experimental studies have shown that disruption of this splice site affects DNAJB2 function (PMID: 22522442). Studies have shown that disruption of this splice site results in complete or partial retention of intron 5 and introduces a premature termination codon (PMID: 22522442). The resulting mRNA is expected to undergo nonsense-mediated decay. For these reasons, this variant has been classified as Pathogenic. - |
Inborn genetic diseases Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 01, 2019 | The c.352+1G>A intronic pathogenic mutation results from a G to A substitution one nucleotide after coding exon 4 of the DNAJB2 gene. This alteration has been detected in the homozygous form in affected individuals and segregates with disease (Blumen SC et al. Ann. Neurol., 2012 Apr;71:509-19; Frasquet M et al. J. Neurol. Neurosurg. Psychiatry, 2016 11;87:1265-1268; Lupo V et al. J Mol Diagn, 2016 Mar;18:225-34). In addition, RNA studies have demonstrated that this alteration results in abnormal splicing, but normal RNA and protein is also detected in individuals homozygous for this alteration (Blumen SC et al. Ann. Neurol., 2012 Apr;71:509-19). Alterations that disrupt the canonical splice site are expected to cause aberrant splicing, resulting in an abnormal protein or a transcript that is subject to nonsense-mediated mRNA decay. As such, this alteration is classified as a disease-causing mutation. - |
DNAJB2-related disorder Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | Sep 08, 2023 | The DNAJB2 c.352+1G>A variant is predicted to disrupt the GT donor site and interfere with normal splicing. This variant was reported in the homozygous state in multiple individuals with distal hereditary motor neuropathy and/or Charcot-Marie-Tooth disease (Blumen et al. 2012. PubMed ID: 22522442; Frasquet et al. 2016. PubMed ID: 27083531; Lupo et al. 2016. PubMed ID: 26752306). This variant is reported in 0.030% of alleles in individuals of Ashkenazi Jewish descent in gnomAD (http://gnomad.broadinstitute.org/variant/2-220146784-G-A). Variants that disrupt the consensus splice donor site in DNAJB2 are expected to be pathogenic. This variant is interpreted as pathogenic. - |
not provided Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Apr 22, 2022 | Functional assay performed on patient's cells demonstrated that c.352+1G>A causes inclusion of intron 5, leading to a truncated protein (Blumen et al., 2012); This variant is associated with the following publications: (PMID: 28018906, 27083531, 26752306, 32093037, 22522442, 31589614, Scalia_2021) - |
Charcot-Marie-Tooth disease X-linked dominant 1 Pathogenic:1
Pathogenic, criteria provided, single submitter | research | Laboratório de Neurologia Aplicada e Experimental, Faculdade de Medicina de Ribeirao Preto – Universidade de Sao Paulo | Jul 20, 2021 | This sequence change falls in intron 5 of the DNAJB2 gene. This mutation causes abnormal splicing of a gene resulting in a quantitative reduction of the protein product (PMID: 22522442). This variant is not present in population databases (GnomAD and ABraOM) in homozygous status. This variant has been reported in the literature in individuals with AR-CMT2 and DSMA5 and is sometimes associated with Parkinson’s disease and cerebellar ataxia (PMID: 22522442; 27083531; DOI: 10.1016/j.parkreldis.2015.10.361). In summary, the c.352+1G>A variant meets our criteria to be classified as pathogenic. - |
Charcot-Marie-Tooth disease Uncertain:1
Uncertain significance, no assertion criteria provided | literature only | Inherited Neuropathy Consortium | - | - - |
Autosomal recessive distal spinal muscular atrophy 2 Uncertain:1
Uncertain significance, no assertion criteria provided | literature only | Inherited Neuropathy Consortium Ii, University Of Miami | Dec 07, 2019 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at